Spain Biomarker Testing Services Market Size & Outlook

The biomarker testing services market in Spain is expected to reach a projected revenue of US$ 32.1 million by 2030. A compound annual growth rate of 8.9% is expected of Spain biomarker testing services market from 2025 to 2030.
Revenue, 2024 (US$M)
$19.4
Forecast, 2030 (US$M)
$32.1
CAGR, 2025 - 2030
8.9%
Report Coverage
Spain

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Spain biomarker testing services market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

Spain biomarker testing services market highlights

  • The Spain biomarker testing services market generated a revenue of USD 19.4 million in 2024 and is expected to reach USD 32.1 million by 2030.
  • The Spain market is expected to grow at a CAGR of 8.9% from 2025 to 2030.
  • In terms of segment, oncology was the largest revenue generating services in 2024.
  • Oncology is the most lucrative services segment registering the fastest growth during the forecast period.

Biomarker testing services market data book summary

Market revenue in 2024USD 19.4 million
Market revenue in 2030USD 32.1 million
Growth rate8.9% (CAGR from 2025 to 2030)
Largest segmentOncology
Fastest growing segmentOncology
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationDrug discovery & development, Oncology
Key market players worldwideEurofins Scientific SE, SGS AG, Charles River Laboratories International Inc, Labcorp Drug Development, Thermo Fisher Scientific Inc, Icon PLC, IQVIA Holdings Inc, Syneos Health, Intertek Group PLC, BioAgilytix Labs

Other key industry trends

  • In terms of revenue, Spain accounted for 3.0% of the global biomarker testing services market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany biomarker testing services market is projected to lead the regional market in terms of revenue in 2030.
  • Germany is the fastest growing regional market in Europe and is projected to reach USD 59.6 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Biomarker Testing Services Market Companies

Name Profile # Employees HQ Website
BioAgilytix Labs View profile 501-1000 Durham, North Carolina, United States, North America http://www.bioagilytix.com
Syneos Health View profile 1001-5000 Morrisville, North Carolina, United States, North America https://www.syneoshealth.com/
Intertek Group PLC View profile 44000 33 Cavendish Square, London, United Kingdom, W1G 0PS https://www.intertek.com
SGS AG View profile 103193 1 Place des Alpes, P.O. Box 2152, Geneva, Switzerland, CH-1211 https://www.sgs.com
IQVIA Holdings Inc View profile 87000 2400 Ellis Road, Durham, NC, United States, 27703 https://www.iqvia.com
Labcorp Drug Development View profile 10001+ Princeton, New Jersey, United States, North America https://drugdevelopment.labcorp.com
Icon PLC View profile 41150 South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 https://www.iconplc.com
Charles River Laboratories International Inc View profile 21400 251 Ballardvale Street, Wilmington, MA, United States, 01887 https://www.criver.com
Eurofins Scientific SE View profile 61798 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 https://www.eurofins.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com

Spain biomarker testing services market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biomarker testing services market will help companies and investors design strategic landscapes.


Oncology was the largest segment with a revenue share of 55.15% in 2024. Horizon Databook has segmented the Spain biomarker testing services market based on drug discovery & development, oncology covering the revenue growth of each sub-segment from 2018 to 2030.


Spain offers high potential in the biomarker testing services market. It is considered lucrative for pharmaceutical companies and research organizations due to its rising number of clinical trials, developing healthcare infrastructure, and robust pharmaceutical & biopharmaceutical industries.

Furthermore, the country has increased requirements for biomarker testing due to proven research quality, high patient recruitment volumes, and a conducive regulatory environment which further contributes as a key player in the clinical research field.

Reasons to subscribe to Spain biomarker testing services market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Spain biomarker testing services market databook

  • Our clientele includes a mix of biomarker testing services market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Spain biomarker testing services market , including forecasts for subscribers. This country databook contains high-level insights into Spain biomarker testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Spain biomarker testing services market size, by services, 2018-2030 (US$M)

Spain Biomarker Testing Services Market Outlook Share, 2024 & 2030 (US$M)

Spain biomarker testing services market size, by services, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online